AU1039292A - Use of nadh and nadph as energy substitutes - Google Patents
Use of nadh and nadph as energy substitutesInfo
- Publication number
- AU1039292A AU1039292A AU10392/92A AU1039292A AU1039292A AU 1039292 A AU1039292 A AU 1039292A AU 10392/92 A AU10392/92 A AU 10392/92A AU 1039292 A AU1039292 A AU 1039292A AU 1039292 A AU1039292 A AU 1039292A
- Authority
- AU
- Australia
- Prior art keywords
- nadh
- nadph
- reduced form
- adenine dinucleotide
- nicotinamide adenine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ACFIXJIJDZMPPO-NCHANQSKSA-N nadph Chemical compound C1=CCC(C(=O)N)=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2[C@@H]([C@H](OP(O)(O)=O)[C@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NCHANQSKSA-N 0.000 title 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 abstract 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 abstract 1
- 229950006238 nadide Drugs 0.000 abstract 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Animal Husbandry (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Detergent Compositions (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Dental Preparations (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Use is described of nicotinamide adenine dinucleotide in its reduced form (NADH) and/or nicotinamide adenine dinucleotide phosphate in its reduced form (NADPH) and/or a physiologically tolerated salt of the same for energy substitution in humans or animals, as is a foodstuff or confectionary product for human consumption or a feedstuff for animal consumption having a content of the substances mentioned.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4102240A DE4102240C1 (en) | 1991-01-24 | 1991-01-24 | |
DE4102240 | 1991-01-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1039292A true AU1039292A (en) | 1992-07-30 |
AU663479B2 AU663479B2 (en) | 1995-10-12 |
Family
ID=6423720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU10392/92A Ceased AU663479B2 (en) | 1991-01-24 | 1992-01-23 | Use of NADH and NADPH as energy substitutes |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0496479B1 (en) |
JP (1) | JP2533709B2 (en) |
AT (1) | ATE112664T1 (en) |
AU (1) | AU663479B2 (en) |
BR (1) | BR9200207A (en) |
CA (1) | CA2059510C (en) |
DE (2) | DE4102240C1 (en) |
DK (1) | DK0496479T3 (en) |
ES (1) | ES2061313T3 (en) |
FI (1) | FI920323A (en) |
HU (1) | HU9200213D0 (en) |
IE (1) | IE69861B1 (en) |
NO (1) | NO304672B1 (en) |
ZA (1) | ZA92275B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2167104A1 (en) * | 1995-01-17 | 1996-07-18 | Joerg G.D. Birkmayer | Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration |
US5712259A (en) * | 1996-04-22 | 1998-01-27 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome |
US5668114A (en) * | 1996-05-08 | 1997-09-16 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating hypertension |
IT1318565B1 (en) * | 2000-06-09 | 2003-08-27 | World Pharma Tech Ltd | NADH OCTOCOSANOL EVITAMIN E PROENERGETIC FOOD SUPPLEMENT |
US20040126751A1 (en) * | 2002-12-27 | 2004-07-01 | Birkmayer Jorg G.D. | Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose |
DE102008010245B4 (en) * | 2008-02-20 | 2011-02-10 | Emag Holding Gmbh | Method for grinding wavy workpieces |
DE102014103443A1 (en) * | 2014-03-13 | 2015-09-17 | Jürgen Ruhlmann | Composition for use in the treatment of fatigue, lack of concentration, withdrawal symptoms, headaches and colds, in particular loss of power, hangover and fatigue |
WO2020021734A1 (en) * | 2018-07-26 | 2020-01-30 | オリジンバイオテクノロジー株式会社 | Functional chicken eggs and method for producing same |
DE202022000567U1 (en) | 2022-03-06 | 2022-03-16 | Penta Phi Eg | Liposomal formulation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3594475A (en) * | 1968-04-24 | 1971-07-20 | Kyowa Hakko Kogyo Kk | Method of treating and preventing the side effects of antibiotics |
DE3380342D1 (en) * | 1982-10-26 | 1989-09-14 | Cta Finanz Ag | Device and process for optimising the tissue mass of organs within the genetic fluctuation range in humans and animals |
IT1162938B (en) * | 1983-08-26 | 1987-04-01 | Dino Spisni | COMPOSITION FOR THE TREATMENT OF MALIGNANT CANCERS, IN PARTICULAR ON ANIMALS |
JPS60126220A (en) * | 1983-12-09 | 1985-07-05 | Otsuka Pharmaceut Factory Inc | Nucleic acid component composition |
ES2007350A6 (en) * | 1987-05-29 | 1989-06-16 | Ganadera Union Ind Agro | Food products enriched with nucleosides and/or nucleotides and preparation thereof. |
JP2736103B2 (en) * | 1988-03-01 | 1998-04-02 | ヴァルター・ビルクマイヤー | Pharmaceutical for treating Parkinson's syndrome and method for producing the same |
AT397201B (en) * | 1988-06-03 | 1994-02-25 | Birkmayer Joerg Ddr | USE OF THE ENZYME COFACTOR NADPH IN THE PRODUCTION OF A MEDICINAL PRODUCT |
-
1991
- 1991-01-24 DE DE4102240A patent/DE4102240C1/de not_active Expired - Lifetime
- 1991-12-27 JP JP3345766A patent/JP2533709B2/en not_active Expired - Fee Related
-
1992
- 1992-01-06 DK DK92250002.0T patent/DK0496479T3/en active
- 1992-01-06 EP EP92250002A patent/EP0496479B1/en not_active Expired - Lifetime
- 1992-01-06 AT AT92250002T patent/ATE112664T1/en not_active IP Right Cessation
- 1992-01-06 ES ES92250002T patent/ES2061313T3/en not_active Expired - Lifetime
- 1992-01-06 DE DE59200603T patent/DE59200603D1/en not_active Expired - Fee Related
- 1992-01-14 ZA ZA92275A patent/ZA92275B/en unknown
- 1992-01-16 CA CA002059510A patent/CA2059510C/en not_active Expired - Fee Related
- 1992-01-23 BR BR929200207A patent/BR9200207A/en not_active Application Discontinuation
- 1992-01-23 IE IE920198A patent/IE69861B1/en not_active IP Right Cessation
- 1992-01-23 HU HU9200213A patent/HU9200213D0/en unknown
- 1992-01-23 NO NO920315A patent/NO304672B1/en not_active IP Right Cessation
- 1992-01-23 AU AU10392/92A patent/AU663479B2/en not_active Ceased
- 1992-01-24 FI FI920323A patent/FI920323A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0496479B1 (en) | 1994-10-12 |
DE4102240C1 (en) | 1992-04-09 |
BR9200207A (en) | 1992-10-06 |
DE59200603D1 (en) | 1994-11-17 |
CA2059510A1 (en) | 1992-07-25 |
CA2059510C (en) | 1997-06-10 |
EP0496479A1 (en) | 1992-07-29 |
ES2061313T3 (en) | 1994-12-01 |
DK0496479T3 (en) | 1995-04-18 |
JP2533709B2 (en) | 1996-09-11 |
AU663479B2 (en) | 1995-10-12 |
FI920323A0 (en) | 1992-01-24 |
ZA92275B (en) | 1992-12-30 |
NO920315D0 (en) | 1992-01-23 |
ATE112664T1 (en) | 1994-10-15 |
NO304672B1 (en) | 1999-02-01 |
NO920315L (en) | 1992-07-27 |
IE69861B1 (en) | 1996-10-16 |
FI920323A (en) | 1992-07-25 |
HU9200213D0 (en) | 1992-04-28 |
IE920198A1 (en) | 1992-07-29 |
JPH05262652A (en) | 1993-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU9062291A (en) | Formulation for treating silage | |
AU653992B2 (en) | Novel benzo-fused lactams that promote the release of growth hormone | |
AU590694B2 (en) | Hydratable powders | |
AU655462B2 (en) | Use of hydrocolloids for formulating and processing of low fat water activity confectionery products and process | |
CA2054358A1 (en) | High acid nutritional formulations | |
CA2102210A1 (en) | Combined Calcium and Vitamin D Supplements | |
AU1039292A (en) | Use of nadh and nadph as energy substitutes | |
DE3867477D1 (en) | PREPARATION FOR EXTENDING THE STABILITY OF FOODS, MEDICINAL PRODUCTS AND COSMETIC PRODUCTS. | |
AU5744286A (en) | Potassium, sodium or calcium formate additive for inhibiting respiration of and promoting desiccation of crops | |
MY106830A (en) | Preparation of a cooked product having an improved preservation based on animal proteins. | |
AU4120589A (en) | Supported lactic acid | |
EP0904701A3 (en) | Inactivated micro-organisms containing minerals, process for their preparation, and their use in the food sector | |
CA2124925A1 (en) | Preparation of dietary fatty acid salt products | |
AU9010991A (en) | Antidepressant | |
ATE217486T1 (en) | PRODUCTION OF A VEGETABLE MILK POWDER | |
GB2016900A (en) | Concentrated food product | |
CA2081348A1 (en) | Veterinary formulation of amoxycillin and clavulanic acid, and derivatives thereof | |
HUT61895A (en) | Process for producing pharmaceutical composition against cancer and aids | |
Annison | Feed enzymes: the science of their use in wheat-based diets | |
AU7392187A (en) | Preparation for prophylaxis and treatment of gastro- intestinal disturbances in farm animals | |
HUT38807A (en) | Flavoured synthetic crisp bone of high hardness |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |